Back
Celldex Therapeutics Stock Price Chart
Access Before Tuesday...
Grab your first two primed-to-double trades here.
Sell
19
CLDX
Celldex Therapeutics
Last Price:
$23.81
Seasonality Move:
0.45%
7 Day Trial
ALL ACCESS PASS
$
7
Hurry! Enter these 2 trades by EOD Tuesday
Click here to access your first two trades.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.43 | Sell |
| 20-day SMA: | 22.21 | Sell |
| 50-day SMA: | 21.48 | Sell |
| 200-day SMA: | 22.47 | Sell |
| 8-day EMA: | 19.4 | Buy |
| 20-day EMA: | 13.54 | Buy |
| 50-day EMA: | 7.1 | Buy |
| 200-day EMA: | 2.06 | Buy |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.75 | Buy |
| Relative Strength Index (14 RSI): | 37.06 | Sell |
| Chaikin Money Flow: | -1079210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.41 - 23.15) | Sell |
| Bollinger Bands (100): | (18.47 - 22.09) | Sell |
Celldex Therapeutics Technical Analysis
| Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
-
Celldex Therapeutics share price is 19.99 while CLDX 8-day simple moving average is 21.43, which is a Sell signal.
-
The stock price of CLDX is 19.99 while Celldex Therapeutics 20-day SMA is 22.21, which makes it a Sell.
-
Celldex Therapeutics 50-day simple moving average is 21.48 while CLDX share price is 19.99, making it a Sell technically.
-
CLDX stock price is 19.99 and Celldex Therapeutics 200-day simple moving average is 22.47, creating a Sell signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
19
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a SellThe current Celldex Therapeutics [CLDX] share price is $19.99. The Score for CLDX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
19.99
Share Volume:
1.5M
Celldex Therapeutics 52-Week Range
52-Week High:
47.00
52-Week Low:
14.40
Sell
19
Celldex Therapeutics (CLDX)
is a Sell
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?The Celldex Therapeutics stock price is 19.99 USD today.
-
Will CLDX stock go up or go down?Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Celldex Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is overvalued.
Is Celldex Therapeutics Stock a Buy?
-
Celldex Therapeutics share price is 19.99 while CLDX 8-day exponential moving average is 19.40, which is a Buy signal.
-
The stock price of CLDX is 19.99 while Celldex Therapeutics 20-day EMA is 13.54, which makes it a Buy.
-
Celldex Therapeutics 50-day exponential moving average is 7.10 while CLDX share price is 19.99, making it a Buy technically.
-
CLDX stock price is 19.99 and Celldex Therapeutics 200-day simple moving average is 2.06, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.26 per share, a decrease this year of $1.06 per share, and a decrease next year of $0.85 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
-
CLDX Moving Average Covergence Divergence (MACD) indicator is 5.75, suggesting Celldex Therapeutics is a Buy
-
Celldex Therapeutics Relative Strength Index (RSI) is 37.06, which suggest Celldex Therapeutics is oversold
-
The Bollinger Bands (25) for Celldex Therapeutics is (21.41 - 23.15), which suggest Celldex Therapeutics is a Sell
-
The Bollinger Bands (100) for Celldex Therapeutics is (18.47 - 22.09), which suggest Celldex Therapeutics is a Sell
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.